Cathay Biotech Inc. (688065.SS)

CNY 53.35

(0.26%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 18.83 Billion 17.82 Billion 16.19 Billion 12.13 Billion 5.98 Billion 4.83 Billion
Total Current Assets 7.57 Billion 8.47 Billion 11.39 Billion 8.44 Billion 2.7 Billion 1.81 Billion
Cash And Short Term Investments 5.39 Billion 6.29 Billion 9.62 Billion 7.03 Billion 1.22 Billion 242.78 Million
Cash and Cash Equivalents 5.39 Billion 6.29 Billion 9.62 Billion 5.7 Billion 366.37 Million 242.78 Million
Short Term Investments 469.24 Thousand 469.24 Thousand 469.24 Thousand 1.33 Billion 859.22 Million -6.5 Million
Net Receivables 672.39 Million 525.86 Million 348.55 Million 332.52 Million 340.76 Million 761.76 Million
Inventory 1.46 Billion 1.57 Billion 1.18 Billion 775.09 Million 830.13 Million 546.14 Million
Other Current Assets 41.23 Million 80.92 Million 231.92 Million 296.79 Million 309.97 Million 265.82 Million
Total Non-Current Assets 11.26 Billion 9.35 Billion 4.8 Billion 3.69 Billion 3.27 Billion 3.02 Billion
Net PPE 10.23 Billion 6.66 Billion 2.98 Billion 2.78 Billion 2.9 Billion 2.69 Billion
Good Will And Intangible Assets 703.85 Million 777.87 Million 768.45 Million 228.44 Million 231.09 Million 216.06 Million
Good Will - - - - - -
Intangible Assets 703.85 Million 777.87 Million 768.45 Million 228.44 Million 231.09 Million 216.06 Million
Long-Term Investments 142.73 Million 49.03 Million 52.74 Million -1.27 Billion -799.42 Million 56.86 Million
Tax Assets 158.87 Million 88.27 Million 49.87 Million 36.65 Million 41.23 Million 22.46 Million
Other Non Current Assets 25.87 Million 1.76 Billion 948.55 Million 1.91 Billion 899.08 Million 34.38 Million
Other Assets - - - 1.00 - -
Total Liabilities 3.65 Billion 2.78 Billion 1.51 Billion 650.73 Million 1.33 Billion 1.68 Billion
Total Current Liabilities 3.4 Billion 1.42 Billion 1.21 Billion 434.76 Million 1.04 Billion 1.5 Billion
Account Payables 1.65 Billion 1.06 Billion 302.25 Million 353.21 Million 746.91 Million 1.15 Billion
Tax Payables 55.54 Million 36.13 Million 50.01 Million 22.28 Million 10.22 Million 21.76 Million
Short Term Debt 1.56 Billion 166.84 Million 743.5 Million -19.89 Million 220.24 Million 128 Million
Deferred Revenue 12.99 Million 17.8 Million 170.25 Million 19.89 Million 57.84 Million 21.76 Million
Other Current Liabilities 184.18 Million 179.47 Million 1.72 Million 81.55 Million 15.06 Million 203.63 Million
Total Non Current Liabilities 245.33 Million 1.36 Billion 293.02 Million 215.97 Million 299.84 Million 174.8 Million
Long-Term Debt 245.33 Million 960.5 Million - - 80 Million -
Deferred Revenue Non Current 405.17 Million 404.38 Million 293.02 Million 214.59 Million 218.63 Million 174.8 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 405.17 Million -960.5 Million - - 1.00 -
Other Liabilities 1.00 - - 1.00 - -
Total Equity 14.77 Billion 15.03 Billion 14.68 Billion 11.48 Billion 4.64 Billion 3.15 Billion
Stock Holders Equity 11.16 Billion 10.94 Billion 10.66 Billion 10.38 Billion 4.64 Billion 3.15 Billion
Common Stock 583.37 Million 583.27 Million 416.68 Million 416.68 Million 375.01 Million 357.15 Million
Retained Earnings 2.06 Billion 1.8 Billion 1.46 Billion 1.19 Billion 784.02 Million 349.49 Million
Accumulated other comprehensive income 225.84 Million 226.82 Million 199.68 Million 184.73 Million 132.79 Million 158.9 Million
Common Stock Equity 11.16 Billion 10.94 Billion 10.66 Billion 10.38 Billion 4.64 Billion 3.15 Billion
Capital Lease Obligation - - - - - -
Total Investments 143.2 Million 49.5 Million 53.21 Million 56.17 Million 59.79 Million 50.36 Million
Total Debt 1.8 Billion 1.12 Billion 743.5 Million - 300.24 Million 128 Million
Net Debt -3.58 Billion -5.16 Billion -8.88 Billion -5.7 Billion -66.13 Million -114.78 Million

Balance Sheet Charts

Created with Highcharts 11.1.0Value in CNYYearly Balance Sheet BreakdownCurrent AssetsNon-Current AssetsCurrent LiabilitiesNon-Current LiabilitiesEquity202020212022202305B10B15B20B
Created with Highcharts 11.1.0Current RatioWorking CapitalAnnual Working CapitalSource: YRWorking CapitalCurrrent Ratio2020202120222023051015202502.5B5B7.5B10B12.5B